Role of lysosomes in physiological activities, diseases, and therapy.

Zhang Z, Yue P, Lu T, Wang Y, Wei Y, Wei X. · 2021

Read Role of lysosomes in physiological activities, diseases, and therapy. by Zhang Z, Yue P, Lu T, Wang Y, Wei Y, Wei X. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8120021.txt.

Introduction

Zhang and co-authors review lysosomes as far more than the cell's stomach. These acid sacs digest worn parts and invaders alike. Newer work casts them as sensing and signaling hubs. They help run nutrient checks and immune defense too. When lysosomes fail, disease follows across the body. The review tours the damage organ by organ.

In clogged arteries and Gaucher disease, sick lysosomes skew macrophage signals. In brain diseases, failed cleanup lets toxic proteins pile up. Pancreatitis and autoimmune disorders carry their own lysosome faults. Tumors lean on lysosomes for growth, spread, and drug resistance. Immune cells inside tumors bend to them as well. Therapies aimed at lysosome proteins now move toward the clinic. Some target the acid pump, others the membrane gates. Restoring the cell's recycling plant is the shared aim.

Catalog record

CREATORZhang Z, Yue P, Lu T, Wang Y, Wei Y, Wei X.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE187 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8120021

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Role of lysosomes in physiological activities, diseases, and therapy By Ziqi Zhang, Pengfei Yue, Tianqi Lu, Yang Wang, Yuquan Wei, Xiawei Wei Published in: Journal of Hematology & Oncology DOI: 10.1186/s13045-021-01087-1 ABSTRACT Long known as digestive organelles, lysosomes have now emerged as multifaceted centers responsible for degradation, nutrient sensing, and immunity. Growing evidence also implicates role of lysosome-related mechanisms in pathologic process. In this review, we discuss physiological function of lysosomes and, more importantly, how the homeostasis of lysosomes is disrupted in several diseases, including atherosclerosis, neurodegenerative diseases, autoimmune disorders, pancreatitis, lysosomal storage disorders, and malignant tumors. In atherosclerosis and Gaucher disease, dysfunction of lysosomes changes cytokine secretion from macrophages, partially through inflammasome activation. In neurodegenerative diseases, defect autophagy facilitates accumulation of toxic protein and dysfunctional organelles leading to neuron death. Lysosomal dysfunction has been demonstrated in pathology of pancreatitis. Abnormal autophagy activation or inhibition has been revealed in autoimmune disorders. In tumor microenvironment, malignant phenotypes, including tumorigenesis, growth regulation, invasion, drug resistance, and radiotherapy resistance, of tumor cells and behaviors of tumor-associated macrophages, fibroblasts, dendritic cells, and T cells are also mediated by lysosomes. Based on these findings, a series of therapeutic methods targeting lysosomal proteins and processes have been developed from bench to bedside. In a word, present researches corroborate lysosomes to be pivotal organelles for understanding pathology of atherosclerosis, neurodegenerative diseases, autoimmune disorders, pancreatitis, and lysosomal storage disorders, and malignant tumors and developing novel therapeutic strategies. BACKGROUND Overview of lysosomes Lysosomes are composed of acid lumen and a layer of lysosomal membrane formed by phospholipid bilayer. The acid lumen contains a host of hydrolytic enzymes, including nucleases, proteases, phosphatases, lipases, sulfatases, and others. These enzymes are synthesized in endoplasmic reticulum, and modified in Golgi, where the proteins are added mannose-6-phosphate residue, a tag targeting lysosomes [1]. On lysosomal membranes, the overarching protein maintaining acid luminal pH is vacuolar H+-ATPase (v-ATPase) that hydrolyses adenosine triphosphate (ATP) to transport protons into lysosomes [2]. Other key lysosomal membrane proteins include several ion channels, through which ions move inward/outward [3]; lysosome-associated membrane proteins (LAMPs), including LAMP1-5, among which LAMP1 and LAMP2 are well documented to be involved in phagocytosis, chaperone-mediated autophagy (CMA), macroautophagy, lipid transport, and aging [4]; soluble N-ethylmaleimide-sensitive factor activating protein receptors (SNAREs) and RAB GTPases that are involved in trafficking and fusion [5]; toll-like receptors (TLRs) that sense pathogen-associated molecular patterns (PAMPs) and initiate inflammatory response [6]; and mammalian target of rapamycin (mTOR) that co-ordinates several homeostatic signaling pathways [7]. Notably, a series of terms have been proposed to classify lysosomes, such as terminal lysosomes, endolysosomes, protolysosomes, phagolysosomes, and autolysosomes indicating heterogeneity of lysosomes. In a word, the complex lysosomal luminal and membrane proteins indicate lysosomes to be pleiotropic organelles. Lysosomes are formed through fusion of endosomes and vesicles budded from trans-Golgi network. The main regulator of lysosomal biogenesis is microphthalmia/transcription factor E (MiT/TFE) protein family including transcription factor EB (TFEB), transcription factor EC (TFEC), transcription factor binding to IGHM enhancer 3 (TFE3), and melanocyte inducing transcription factor (MITF) [8], among which TFEB is the best studied. TFEB can be phosphorylated on several sites by a number of kinases and phosphatases, such as mechanistic target of rapamycin complex 1 (mTORC1) on Ser211 [9], Ser142 [10], and Ser122 [11], glycogen synthase kinase 3β (GSK3β) on Ser134 and Ser138 [12], extracellular signal-regulated kinase (ERK) on Ser142 [13], mitogen-activated protein kinase kinase kinase kinase 3 (MAP4K3) on Ser3 [14], and protein kinase B (PKB) on Ser467 [15] repressing nuclear translocation of TFEB. Dephosphorylation of TFEB by calcineurin [16] and protein phosphatase 2 (PP2A) [17] lets TFEB enter nuclear to regulate transcription. For example, if nutrient is in abundance, TFEB is phosphorylated by mTORC1, which facilitates 14-3-3-dependent retention of TFEB in cytoplasm and prevents transcription function of TFEB [9]. On the contrary, in the context of starvation or mTOR inhibitor treatment, inactivated mTOR leads to accumulation of dephosphorylated TFEB resulting in nuclear translocation of TFEB [10]. Alternatively, in some cases, lysosomes release Ca2+ through transient receptor potential mucolipin 1 (TRPML1) to activate calcineurin that dephosphorylates TFEB [16]. In nucleus, TFEB transcribes coordinated lysosomal expression and regulation (CLEAR) network genes that code proteins highly related to structure and function of lysosomes [18] including receptors and enzymes participating in lysosomal sorting. Both soluble and membrane lysosomal proteins should be recognized by sorting receptors. The best-known sorting receptor is the mannose-6-phosphate receptors (M6PRs) that recognize M6P-tagged proteins in the Golgi complex [19]. Newly synthesized lysosomal proteins are successively modified by oligosaccharyltransferase [20], GlcNAc-1-phosphotransferase, and uncovering enzyme [21] to be tagged with M6P residues. In Golgi complex with pH 6.7, tagged proteins bind with M6PRs, while in acidic endosomes with pH 6, the proteins are released [19]. Additionally, a subgroup of M6PRs, cation-independent MPR, is able to localize at plasma membrane, which underpins retrieving of escaped extracellular lysosomal proteins [19]. Besides M6PRs, two sorting receptors are also found, sortilin and lysosomal integral membrane protein 2 (LIMP-2). Sortilin is involved in the sorting of prosaposin [22], acid sphingomyelinase [23], cathepsin D, and cathepsin H [24]. LIMP-2 mediates the transport of β-glucocerebrosidase [25], whose dysfunction is associated with Gaucher disease (GD). For lysosomal membrane proteins, tyrosine-based or dileucine-based signals are essential for their lysosomal targeting through adaptor proteins or Golgi-localising, Gamma-adaptin ear domain homology, ARF-binding proteins (GGAs) [26, 27]. Early endosomes budding from post-Golgi complex engage multiple rounds of membrane fusion and fission, resulting in formation of late endosomes and lysosomes [28, 29]. In a word, the lysosomal biogenesis pathway is accurately controlled to keep the homeostasis of cell. Function of lysosomes Recent discoveries have changed the former consideration of lysosomes as organelles that degrade and recycle cellular waste. It is now clear that lysosomes are key organelles in degradation, innate and adaptive immunity, and nutrient sensing [28]. Tempting researches have highlighted many signal pathways interacting with lysosomal activities manifesting the central role of lysosomes in many physiological processes [29]. In addition, progressions of several diseases are also regulated by lysosomes [30]. Autophagy Lysosomal degradation is classified as endocytosis and autophagy that is composed of macroautophagy, microautophagy, and CMA. Cytoplasmic materials, like mitochondria, are recycled through macroautophagy triggered by Unc-51-like kinase (ULK) complex and phosphatidylinositol 3-kinase (PI3K) complex, during which double-membrane phagophores are formed and then mature into autophagosomes [31]. To undergo degradation, autophagosomes then fuse with lysosomes with help of microtubule-associated protein 1A/B light chain 3B (LC3B)-I/II [32]. Microautophagy is described as a concise process that lysosome directly engulfs cytosolic material via invagination of lysosomal membrane under the mediation of vacuolar protein sorting 4 (VPS4) and ALG-2 interacting protein X (ALIX) [33]. In CMA, cytosolic soluble proteins are recognized through KFERQ-like motif by complex containing members of heat shock proteins (HSPs), HSPA8/HSC70. Then the proteins are translocated into the lysosomal lumen with help of lysosome-associated membrane protein type 2A (LAMP2A) for degradation [34]. At present, the mechanisms of autophagy have been intensively studied, thus demonstrating autophagy dysfunction to be a crucial step in the pathology of many diseases and a target for interventions. Innate and adaptive immunity Immunity is directly impacted by lysosomal activities in cells like DCs and macrophages. For innate immunity, pathogens like bacteria are internalized through phagocytosis and targeted to lysosomes for degradation. In

Read the complete text